Alterity Therapeutics

+$0.20 (+14.29%) Today
-$0.07 (-4.49%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.

About ATHE

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders.

CEO
David A. Stamler
Employees
12
Headquarters
Melbourne, Victoria (VIC)
Founded
1997

ATHE Key Statistics

Market Cap
62.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
859.62K
High Today
$1.82
Low Today
$1.45
Open Price
$1.68
Volume
61.53M
52 Week High
$5.15
52 Week Low
$1.09

ATHE Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure